Edition:
United States

Humanwell Healthcare Group Co Ltd (600079.SS)

600079.SS on Shanghai Stock Exchange

18.29CNY
11 Dec 2017
Change (% chg)

¥0.28 (+1.55%)
Prev Close
¥18.01
Open
¥18.03
Day's High
¥18.36
Day's Low
¥17.92
Volume
10,834,479
Avg. Vol
10,964,064
52-wk High
¥21.50
52-wk Low
¥17.31

Latest Key Developments (Source: Significant Developments)

Humanwell Healthcare Group unit gets approval of clinical trial for Meisuoshuli tablets
Wednesday, 6 Dec 2017 03:22am EST 

Dec 6 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS> ::Says its Wuhan-based unit gets approval of clinical trial for Meisuoshuli tablets, which is used for anti-inflammatory, analgesic and antipyretic .  Full Article

Humanwell Healthcare's shareholder bought shares worth 143.7 mln yuan during Jun 28-Nov 29
Wednesday, 29 Nov 2017 03:27am EST 

Nov 29 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>::SAYS CONTROLLING SHAREHOLDER HAS BOUGHT 143.7 MILLION YUAN ($21.78 million) WORTH OF COMPANY SHARES BETWEEN JUNE 28 AND NOV 29.  Full Article

Humanwell Healthcare Group unit passes FDA approval
Thursday, 23 Nov 2017 03:25am EST 

Nov 23(Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says its 75 percent-owned unit received approval for its soft capsule named Dutasteride Capsule from U.S Food and Drug Administration .Says the unit will be able to sell Dutasteride Capsule in the United States after receiving the FDA approval.  Full Article

Humanwell Healthcare to sell bio-pharma firm for 350 mln yuan
Wednesday, 22 Nov 2017 03:11am EST 

Nov 22 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says it plans to sell bio-pharma firm for 350 million yuan ($52.90 million).  Full Article

Humanwell Healthcare and unit to increase stake in Tianfeng Securities
Friday, 10 Nov 2017 05:19am EST 

Nov 10 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says it and unit plan to acquire additional 2.18 percent stake in Tianfeng Securities for 305.1 million yuan ($45.97 million).  Full Article

Humanwell Healthcare Group completes issuance of 67.7 mln A shares in private placement
Tuesday, 7 Nov 2017 02:01am EST 

Nov 7 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS> ::Says it completed issuance of 67.7 million A shares of the company and raised 1.19 billion yuan in private placement .  Full Article

Humanwell Healthcare's 9-month net profit up 211.3 pct y/y
Monday, 30 Oct 2017 04:26am EDT 

Oct 30 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says 9-month net profit up 211.3 percent y/y.  Full Article

Humanwell Healthcare Group unit receives approval for drug clinical trial
Friday, 27 Oct 2017 06:01am EDT 

Oct 27(Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says unit Yichang Humanwell pharmaceutical Co Ltd received approval for drug clinical trial for a kind of injection M6G, from China Food and Drug Administration .  Full Article

Humanwell Healthcare Group unit receives FDA approval
Tuesday, 10 Oct 2017 10:34pm EDT 

Oct 11 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:* Says its unit, PuraCap Pharmaceutical LLC, received approval for its Pioglitazone Tablet from U.S Food and Drug Administration .* Says its unit will be able to sell its Pioglitazone Tablet in the United States after receiving the FDA approval.  Full Article

Humanwell Healthcare Group jointly acquires sexual health business of Ansell Ltd with CITIC Capital Cupid Investment
Tuesday, 10 Oct 2017 05:33am EDT 

Oct 10 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:* Says it acquired Wuhan-based sanitation supplies unit of Ansell Ltd. for $120 million .* Says unit RFSW Investment Pte. Ltd. set up a JV, Lifestyles Holdco Pte. Ltd, with CITIC Capital Cupid Investment Limited and the JV acquired sexual health business in world (except China) for $400 million .  Full Article

BRIEF-Humanwell Healthcare Group unit gets approval of clinical trial for Meisuoshuli tablets

* Says its Wuhan-based unit gets approval of clinical trial for Meisuoshuli tablets, which is used for anti-inflammatory, analgesic and antipyretic